Maha Othman – ”BIC 2025 is Without a Doubt a Remarkable Scientific Event — and I’m Excited for What Lies Ahead!”
Maha Othman, Editor-in-Chief of Current Opinion in Hematology Journal, Research Co-Lead at CanVECTOR Research Network, shared on LinkedIn:
”Just returned from my first BIC – and what an experience!
A niche and well-organized conference, BIC 2025 brought together cutting-edge science, rich discussions, and an inspiring community of experts — all set in the beautiful city of Padua.
I had the opportunity to present novel AI-driven data on G14, a potent peptide inhibitor that disrupts the Platelet–VWF interaction.
This research has promising diagnostic and therapeutic potential in PT-VWD and Type 2B VWD; two bleeding disorders.
Proud to share that this collaborative work — between my lab at Queen’s University ’, Thomas Kazmirchuk, Ashkan Golshani Lab at Carleton University — has just been published in Blood Advances.
It was also a pleasure catching up with so many respected colleagues mentors and brilliant minds in the field — Glenn F. Pierce, David Lillicrap, Bernhard Lämmle, Augusto Federici, Cécile Denis, Caterina Casari, Edward Tuddenham, Wolfgang Miesbach …many others and meet rising stars/ make new friends like Gregory Newby, Alexander Tischer and Mathew Auton.
Akso got a chance to see/ experience a glimpse of the fascinating Italian culture , food and architecture Venice, Padua
A special thanks to Flora Peyvandi for decades of research and leadership in this field, and to the BIC organizing committee for the kind invitation.
Always grateful to St. Lawrence College for supporting professional development and quality research.
Thanks to all my students waiting for me to come back to resume our teaching / learning journey and career building!
BIC 2025 is without a doubt a remarkable scientific event — and I’m excited for what lies ahead!”
More from BIC 2025 featured in Hemostasis Today.
-
Nov 2, 2025, 14:172019 ESC/EAS Guidelines for the Management of Dyslipidaemias Discussion with Lale Tokgözoğlu and Jeanine Roeters van Lennep
-
Nov 2, 2025, 14:14Nihar Desai: Post-Transplant Dysphagia
-
Nov 2, 2025, 14:13Zia Choudhry Launchs a New Digital Education Platform Designed to Inform and Empower People Living With wAIHA
-
Nov 2, 2025, 14:13Rahul Bhargava: Landmark Study Shows Excellent Outcomes in Pediatric AML Transplant
-
Nov 2, 2025, 10:17ESO: Register for the Live WSC 2025 Highlights Webinar
-
Nov 2, 2025, 14:21Claude Franceschi: I Advise You to Understand the Hemodynamic Pathophysiology of Venous Diseases Rather than Blindly Applying Ablation Techniques or Venous Stent Placement
-
Nov 2, 2025, 14:15Krishna Aragam: Why are (DCM) and Heart Failure About Twice as Common in Individuals of Self-Identified Black Race?
-
Nov 2, 2025, 14:15Raul Santos: Waist-to-Height Ratio and Coronary Artery Calcium Incidence
-
Nov 2, 2025, 14:12Steven AR Murphy: Urolithin A Shows Immune Rejuvenation and Mitochondrial Benefits in New Trial
-
Nov 2, 2025, 10:31Cihan Ay and RIETE Investigators Team Present External Validation of the VTE-PREDICT Score
-
Oct 29, 2025, 07:31The Use of Artificial Intelligence to Improve Detection of Acute Incidental Pulmonary Emboli - JTH
-
Oct 29, 2025, 07:05Shrinidhi Nathany: AI in Diagnostic Medicine
-
Oct 28, 2025, 07:02Aya Berman: AI Model for Predicting Bacteremia
-
Oct 28, 2025, 06:55The New Era of Genomics, AI and Cell Therapy in Hematology and Infectious Diseases
-
Oct 28, 2025, 06:49Lukas Gaats: Researchers Are Building Reproductive Organoids
-
Nov 2, 2025, 14:17Anamaria B: Your Mother Still Runs Part of Your DNA
-
Nov 2, 2025, 10:57Paul Bolaji on Launching The First Centralised Nigerian National Stroke Registry
-
Nov 2, 2025, 10:03Mark Stoffels: A Stroke Can Change Lives in an Instant, But With Timely Expert Care Recovery is Possible
-
Nov 2, 2025, 09:43Louise Bannon Celebrates Barbara Adams Krolak’s 10-Year Anniversary at ISTH
-
Nov 2, 2025, 08:06Sanam Loghavi Recognized at Inaugural Women in Hematology U.S. Focus Meeting 2025